HU9400932D0 - Linear adhesion inhibitors - Google Patents

Linear adhesion inhibitors

Info

Publication number
HU9400932D0
HU9400932D0 HU9400932A HU9400932A HU9400932D0 HU 9400932 D0 HU9400932 D0 HU 9400932D0 HU 9400932 A HU9400932 A HU 9400932A HU 9400932 A HU9400932 A HU 9400932A HU 9400932 D0 HU9400932 D0 HU 9400932D0
Authority
HU
Hungary
Prior art keywords
adhesion inhibitors
linear adhesion
linear
inhibitors
adhesion
Prior art date
Application number
HU9400932A
Other languages
English (en)
Inventor
Beate Diefenbach
Brunhilde Felding-Habermann
Alfred Jonczyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HU9400932D0 publication Critical patent/HU9400932D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU9400932A 1993-04-01 1994-03-31 Linear adhesion inhibitors HU9400932D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4310632A DE4310632A1 (de) 1993-04-01 1993-04-01 Lineare Adhäsionsinhibitoren

Publications (1)

Publication Number Publication Date
HU9400932D0 true HU9400932D0 (en) 1994-06-28

Family

ID=6484423

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9400932A HU9400932D0 (en) 1993-04-01 1994-03-31 Linear adhesion inhibitors

Country Status (10)

Country Link
EP (1) EP0618225A1 (hu)
JP (1) JPH06321988A (hu)
CN (1) CN1099040A (hu)
AU (1) AU5798494A (hu)
CA (1) CA2120302A1 (hu)
CZ (1) CZ70394A3 (hu)
DE (1) DE4310632A1 (hu)
HU (1) HU9400932D0 (hu)
NO (1) NO941151L (hu)
SK (1) SK38494A3 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US5874562A (en) * 1995-06-07 1999-02-23 Progenitor, Inc. Nucleic acid encoding developmentally-regulated endothelial cell locus-1
MX9801716A (es) * 1995-08-30 1998-05-31 Searle & Co Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
IL125756A (en) 1996-02-15 2003-05-29 Biosense Inc Catheter for use in surgery
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
DE69838526T2 (de) 1998-02-05 2008-07-03 Biosense Webster, Inc., Diamond Bar Gerät zum Freisetzen eines Medikaments im Herzen
WO2000038715A2 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. Use of an integrin antagonist and radiation in the treatment of neoplasia
CA2412011A1 (en) 2000-06-16 2001-12-27 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
ATE480561T1 (de) 2004-10-19 2010-09-15 Lonza Ag Verfahren zur festphasen-peptidsynthese
US20100323950A1 (en) * 2007-09-11 2010-12-23 Dorian Bevec Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
EP2187955A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Therapeutic use of peptide yglf and combination with kvlpvpq
CN106279362B (zh) * 2015-06-23 2019-07-12 首都医科大学 Arg-Leu-Val-Cys-Val，其合成，药理活性和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049659A (en) * 1988-02-09 1991-09-17 Dana Farber Cancer Institute Proteins which induce immunological effector cell activation and chemattraction
US5196511A (en) * 1989-12-01 1993-03-23 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding

Also Published As

Publication number Publication date
AU5798494A (en) 1994-10-06
JPH06321988A (ja) 1994-11-22
NO941151D0 (no) 1994-03-29
CZ70394A3 (en) 1994-12-15
EP0618225A1 (de) 1994-10-05
NO941151L (no) 1994-10-03
CN1099040A (zh) 1995-02-22
CA2120302A1 (en) 1994-10-02
SK38494A3 (en) 1995-02-08
DE4310632A1 (de) 1994-10-06

Similar Documents

Publication Publication Date Title
PL320995A1 (en) Fibronectin adhesion inhibitors
AU2067892A (en) Corrosion inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
PL304270A1 (en) Pipeline
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
PL316071A1 (en) Cyclic adhesion inhibitors
AU648907B2 (en) Corrosion inhibitors
IL123653A0 (en) Chemokine inhibitor
HUP9903631A3 (en) Adhesion inhibitors
HU9400932D0 (en) Linear adhesion inhibitors
GB9315846D0 (en) Tumour inhibitors
GB9425923D0 (en) Labelling
HU9503783D0 (en) Squvalen syntetase inhibitors
DE69523450D1 (en) Inhibitor
GB9321917D0 (en) Corrosion inhibitors
ZA949525B (en) Enzyme inhibitors
GB9319252D0 (en) Pathway inhibitors
PL314796A1 (en) Wet-wiping floor-care coating
GB9308946D0 (en) Macrophage adhesion
GB9315163D0 (en) Macrophage adhesion
GB9322571D0 (en) Adhesives
GB9319663D0 (en) Enzyme inhibitors
GB9324981D0 (en) Enzyme inhibitors
ZA934819B (en) Cyclic adhesion inhibitors.
GB9311903D0 (en) Coating surfaces